EDG7 Antibody Blocking peptide
EDG7 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Lysophosphatidic acid receptor 3, LPA receptor 3, LPA-3, Lysophosphatidic acid receptor Edg-7, LPAR3, EDG7, LPA3
UniProt
Q9UBY5
Field of Research
Epigenetics, GPCR, Neuroscience, Signaling Pathways
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the C-term region of human EDG7 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
035058 200 µL
EME2, CT (EME2, Probable crossover junction endonuclease EME2)
Sign In for Pricing
View Details